Provided by Tiger Trade Technology Pte. Ltd.

JENSCARE-B

7.395
+0.0100.14%
Volume:22.20K
Turnover:162.42K
Market Cap:3.08B
PE:-9.89
High:7.645
Open:7.385
Low:6.950
Close:7.385
52wk High:11.980
52wk Low:6.000
Shares:417.17M
HK Float Shares:310.31M
Volume Ratio:1.39
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.748
ROE:-19.02%
ROA:-10.11%
PB:3.52
PE(LYR):-9.89
PS:18.69

Loading ...

Jenscare Scientific Says Jensclip Transcatheter Valve Repair System Receives NMPA Registration Approval

Reuters
·
Sep 23

Jenscare Scientific's Valve Repair System Gets Registration Nod in China

MT Newswires Live
·
Sep 22

JENSCARE-B (09877) Secures NMPA Registration Approval for JensClip and Accelerates Commercial Rollout

Stock News
·
Sep 22

Jenscare Scientific Co - Jensclip Transcatheter Valve Repair System Receives Nmpa Registration Approval

THOMSON REUTERS
·
Sep 22

Jenscare Scientific Co - Company Actively Pursuing Commercialization of Jensclip in China and Other Markets

THOMSON REUTERS
·
Sep 22

Jenscare Scientific Secures Hong Kong Approval for Heart Valve System

MT Newswires Live
·
Sep 07

Jenscare Says LuX-Valve Plus Wins Hong Kong Health Regulator Approval

Reuters
·
Sep 04

Jenscare Scientific Co - Lux-Valve Plus Receives Approval from Hong Kong Department of Health

THOMSON REUTERS
·
Sep 04

Revenue Surge Signals Commercial Turning Point as JENSCARE-B (09877) Leverages Innovation for Global Competition and Steadily Enhances Market Standing

Stock News
·
Sep 03

Jenscare Scientific (SEHK:9877) Stock Rallies Into A Steep Valuation Puzzle

Simply Wall St.
·
Sep 01

JENSCARE-B Posts Strong First-Half Results with 377.7% Revenue Surge

Stock News
·
Aug 31

Jenscare FY26 H1 Net Loss Narrows 71.4% to RMB 48.76 Million; Revenue Rises 377.7% to RMB 64.13 Million

Reuters
·
Aug 31

Jenscare Scientific Sets 31 Aug 2026 Board Meeting to Approve 1H26 Results and Potential Interim Dividend

Bulletin Express
·
Aug 19

Jenscare Scientific Schedules Board Meeting to Review Interim Results, Consider Dividend

Reuters
·
Aug 19

Jenscare Scientific Expects Revenue to Jump Up to 400% in H1

MT Newswires Live
·
Aug 10

JENSCARE-B (09877) Forecasts Mid-Year Revenue Surge of 385% to 400%

Stock News
·
Aug 10

Jenscare Scientific Co - Forecasts 2026 Interim Revenue of RMB63 Mln–RMB65 Mln, up 385%-400% Y/Y

THOMSON REUTERS
·
Aug 10

Jenscare Completes First Implants in FDA Pivotal Trial for Lux-valve Plus Tricuspid Valve System

Reuters
·
Jul 16

JENSCARE-B Shares Surge Following EU Regulatory Approval for Key Heart Valve System

Stock News
·
Jul 08

Jenscare Scientific Says Lux-valve Plus Obtains EU MDR CE Certification

Reuters
·
Jul 08